Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
5.84
+0.32 (5.80%)
At close: Nov 13, 2026, 4:00 PM EST
5.84
0.00 (0.00%)
After-hours: Nov 13, 2026, 4:15 PM EST
Cytek Biosciences Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Cytek Biosciences stock has a consensus rating of "Buy" and an average price target of $6.50. The average 1-year stock price forecast is 11.30% higher than the current stock price, while the lowest is $5.00 (-14.38%) and the highest is $7.50 (+28.42%).
Price Target: $6.50 (+11.30%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cytek Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens | Stephens | Buy Reiterates $7 | Buy | Reiterates | $7 | +19.86% | Nov 10, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $5 | Hold | Maintains | $5 | -14.38% | Nov 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $7.5 | Buy | Reiterates | $7.5 | +28.42% | Nov 5, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $5.5 → $5 | Hold | Maintains | $5.5 → $5 | -14.38% | Oct 9, 2026 |
Financial Forecast
Revenue This Year
209.22M
from 201.49M
Increased by 3.83%
Revenue Next Year
222.77M
from 209.22M
Increased by 6.48%
EPS This Year
-0.12
from -0.31
EPS Next Year
0.07
from -0.12
EPS and Forward PE are based on non-GAAP adjusted numbers.